|4Jan 5, 4:35 PM ET

ZIOPHARM ONCOLOGY INC 4

4 · ZIOPHARM ONCOLOGY INC · Filed Jan 5, 2016

Insider Transaction Report

Form 4
Period: 2015-12-31
BELBEL CAESAR J
EVP, Chief Legal Officer & Sec
Transactions
  • Award

    Common Stock

    2015-12-31+65,000124,201 total
Footnotes (1)
  • [F1]21,666 shares shall vest on 12/31/2016; 21,667 shares shall vest on each of 12/31/2017 and 12/31/2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION